Stock Information
Spyre Therapeutics Inc (SYRE)
Ticker Symbol: SYRE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,002.82 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -2.3222
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -24.32%
Latest News
-
Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday
Tue, Aug 11, 2026 7:59 AM
-
BTIG Maintains Buy on Spyre Therapeutics, Raises Price Target to $132
Tue, Aug 11, 2026 6:22 AM
-
Spyre Therapeutics Launches New Combination Program SPY772, Comprising Long-Acting Anti-TL1A Antibody SPY072 And Novel Long-Acting Anti-IL-17A/F Antibody In Preclinical Development SPY007
Mon, Aug 10, 2026 8:04 AM
Key Financials
Financial data not available
